Table 7.
Neph1 | Nephrin | |
---|---|---|
FSGS | ↓ | → |
FPE areas | ↓ | → |
non-FPE areas | ↓ | → |
MCNS | ↓ | ↓ |
FPE areas | ↓ | ↓ |
non-FPE areas | ↓ | ↓ |
ADR, day 7 | ↓ | → |
FPE areas | ↓ | → |
non-FPE areas | ↓ | → |
ADR, day 14 | ↓ | ↓ |
FPE areas | ↓ | → |
non-FPE areas | ↓ | → |
PAN, day 2 | ↓ | ↓a |
FPE areas | → | ↓a |
non-FPE areas | ↓ | ↓a |
PAN, day 4 | ↓ | ↓a |
FPE areas | ↓ | ↓a |
non-FPE areas | ↓ | ↓a |
↓ = Significantly reduced (p < 0.05); → = no change compared to controls.
Previously published [7].